Invirase (Saquinavir Mesylate) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - March 28, 2018 Category: Drugs & Pharmacology Source Type: news

Ilumya (Tildrakizumab-asmn Injection, for Subcutaneous Use) - new on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - March 28, 2018 Category: Drugs & Pharmacology Source Type: news

Cefdinir vs. cefixime (Suprax) 3rd Generation Antibiotics
Title: Cefdinir vs. cefixime (Suprax) 3rd Generation AntibioticsCategory: MedicationsCreated: 3/28/2018 12:00:00 AMLast Editorial Review: 3/28/2018 12:00:00 AM (Source: MedicineNet Medications General)
Source: MedicineNet Medications General - March 28, 2018 Category: Drugs & Pharmacology Source Type: news

Mylan Introduces Symfi (efavirenz, lamivudine and tenofovir disoproxil fumarate) Triple Combo Once-Daily HIV Treatment in the U.S.
HERTFORDSHIRE, England and PITTSBURGH, March 28, 2018 /PRNewswire/ -- Global pharmaceutical company Mylan N.V. (NASDAQ: MYL) today announced that it will introduce in the U.S. a third cost-saving HIV combination. The U.S. Food and Drug... (Source: Drugs.com - New Drug Approvals)
Source: Drugs.com - New Drug Approvals - March 28, 2018 Category: Drugs & Pharmacology Source Type: news

Study changes long-held concepts of cell decoding
(NIH/National Institute on Drug Abuse) Scientists at the National Institute on Drug Abuse Intramural Research Program have uncovered evidence that shows a more complex and elaborate role for the body's hard-working G protein-coupled receptors than previously thought, suggesting a conceptual advance in the fields of biochemistry and pharmacology. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - March 28, 2018 Category: International Medicine & Public Health Source Type: news

Bristol study on nicotinic receptors and long-term memory could lead to more targeted and effective therapies for dementia
A new University of Bristol study, which identifies how acetylcholine impacts learning and memory by acting at different receptors, could prove significant in the drive to develop more targeted and effective therapies for dementia. (Source: University of Bristol news)
Source: University of Bristol news - March 27, 2018 Category: Universities & Medical Training Tags: Health, International, Postgraduate, Public engagement, Research; Faculty of Biomedical Sciences, Faculty of Biomedical Sciences, School of Physiology, Pharmacology and Neuroscience; Press Release Source Type: news

RPS welcomes sildenafil in community pharmacies
The Royal Pharmaceutical Society fully supports the move to make sildenafil available at community pharmacies as a P medicine so it can be provided directly by pharmacists after a consultation with a (Source: Royal Pharmaceutical Society News)
Source: Royal Pharmaceutical Society News - March 27, 2018 Category: Drugs & Pharmacology Source Type: news

Tofacitinib and Biological Therapies for Ulcerative Colitis Tofacitinib and Biological Therapies for Ulcerative Colitis
Tofacitinib is currently under review as induction and/or maintenance therapy for adult patients with moderate-to-severe ulcerative colitis. How does it compare with other biologics?Alimentary Pharmacology & Therapeutics (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - March 27, 2018 Category: Consumer Health News Tags: Gastroenterology Journal Article Source Type: news

FDA Advisory Committee Votes in Favor of Lucemyra (lofexidine) for the Mitigation of Opioid Withdrawal Symptoms
LOUISVILLE, Ky., March 27, 2018 /PRNewswire/ -- US WorldMeds today announced that the US Food and Drug Administration (FDA) Psychopharmacologic Drugs Advisory Committee voted 11 to 1 to recommend approval of lofexidine for mitigating opioid... (Source: Drugs.com - New Drug Applications)
Source: Drugs.com - New Drug Applications - March 27, 2018 Category: Drugs & Pharmacology Source Type: news

FDA Approves Toujeo (insulin glargine) Max SoloStar
BRIDGEWATER, N.J., March 27, 2018 /PRNewswire/ -- The U.S. Food and Drug Administration (FDA) approved Sanofi's Toujeo (insulin glargine 300 Units/mL) Max SoloStar, the highest capacity long-acting insulin pen that will be available on the... (Source: Drugs.com - New Drug Approvals)
Source: Drugs.com - New Drug Approvals - March 27, 2018 Category: Drugs & Pharmacology Source Type: news

Product Name Placement, Size, and Prominence in Advertising and Promotional Labeling
Advertising (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - March 26, 2018 Category: Drugs & Pharmacology Source Type: news

Zuplenz (Ondansetron Oral Soluble Film) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - March 26, 2018 Category: Drugs & Pharmacology Source Type: news

Xatmep (Methotrexate Oral Solution) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - March 26, 2018 Category: Drugs & Pharmacology Source Type: news

Lexicon Pharmaceuticals Announces Regulatory Submissions for Sotagliflozin to Treat Adults with Type 1 Diabetes
The Woodlands, Texas, March 26, 2018 - Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX), today announced that its collaborator, Sanofi, has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) and a Marketing... (Source: Drugs.com - New Drug Applications)
Source: Drugs.com - New Drug Applications - March 26, 2018 Category: Drugs & Pharmacology Source Type: news

Loxo Oncology Completes Rolling Submission of New Drug Application to U.S. Food and Drug Administration for Larotrectinib for the Treatment of TRK Fusion Cancer
STAMFORD, Conn., March 26, 2018 (GLOBE NEWSWIRE) -- Loxo Oncology, Inc. (Nasdaq:LOXO), a biopharmaceutical company innovating the development of highly selective medicines for patients with genetically defined cancers, today announced that the... (Source: Drugs.com - New Drug Applications)
Source: Drugs.com - New Drug Applications - March 26, 2018 Category: Drugs & Pharmacology Source Type: news

Palatin Technologies Announces Submission of Bremelanotide NDA to FDA for Treatment of Hypoactive Sexual Desire Disorder (HSDD) in Premenopausal Women
CRANBURY, N.J., March 26, 2018 /PRNewswire/ -- Palatin Technologies, Inc. (NYSE American: PTN), a biopharmaceutical company developing targeted, receptor-specific peptide therapeutics for the treatment of diseases with significant unmet medical... (Source: Drugs.com - New Drug Applications)
Source: Drugs.com - New Drug Applications - March 26, 2018 Category: Drugs & Pharmacology Source Type: news

Phenytoin Sodium Injection, USP (Updated - Currently in Shortage)
Drug Shortage (Source: FDA Drug Shortages)
Source: FDA Drug Shortages - March 23, 2018 Category: Drugs & Pharmacology Source Type: news

Ropivacaine Hydrochloride injection (Updated - Currently in Shortage)
Drug Shortage (Source: FDA Drug Shortages)
Source: FDA Drug Shortages - March 23, 2018 Category: Drugs & Pharmacology Source Type: news

How Social Media Can Reveal Overlooked Drug Reactions
Even big clinical studies can miss important drug side effects. Researchers, doctors and drugmakers are looking at patients' experiences posted on social media for clues on problems that were missed.(Image credit: Roy Scott/Getty Images/Ikon Images) (Source: NPR Health and Science)
Source: NPR Health and Science - March 23, 2018 Category: Consumer Health News Authors: Menaka Wilhelm Source Type: news

Antihistamines vs. Corticosteroids
Title: Antihistamines vs. CorticosteroidsCategory: MedicationsCreated: 3/23/2018 12:00:00 AMLast Editorial Review: 3/23/2018 12:00:00 AM (Source: MedicineNet Medications General)
Source: MedicineNet Medications General - March 23, 2018 Category: Drugs & Pharmacology Source Type: news

AIDS Researcher Robert Redfield Is the New CDC Director. Here ’s Why the Pick Is Controversial
The Trump administration has tapped HIV researcher Dr. Robert Redfield to be the new leader of the U.S. Centers for Disease Control and Prevention (CDC), Redfield will be replacing Dr. Brenda Fitzgerald, who stepped down from CDC director after Politico reported that she had bought shares in a tobacco company after accepting the position. Redfield will not require Senate confirmation. However, reactions to his selection have been mixed. Before joining the CDC, Redfield was a professor at the University of Maryland School of Medicine and the co-founder of the university’s Institute of Human Virology. Over his career, ...
Source: TIME: Health - March 22, 2018 Category: Consumer Health News Authors: Alexandra Sifferlin Tags: Uncategorized CDC CDC Director Dr. Robert Redfield healthytime public health Scientific misconduct Source Type: news

Labeling for Bronchodilators: Cold, Cough, Allergy, Bronchodilator, And Antiasthmatic Drug Products for Over-the-Counter Human Use (Small Entity Compliance Guide)
Over-the-Counter; Small Entity Compliance Guide (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - March 22, 2018 Category: Drugs & Pharmacology Source Type: news

Q8, Q9, & Q10 Questions and Answers -- Appendix: Q & As from Training Sessions (Q8, Q9, & Q10 Points to Consider)
International Council on Harmonisation - Quality (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - March 22, 2018 Category: Drugs & Pharmacology Source Type: news

S6(R1) Preclinical Safety Evaluation of Biotechnology-Derived Pharmaceuticals
International Council on Harmonisation - Safety (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - March 22, 2018 Category: Drugs & Pharmacology Source Type: news

Symfi Lo (Efavirenz, Lamivudine and Tenofovir Disoproxil Fumarate Tablets) - new on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - March 22, 2018 Category: Drugs & Pharmacology Source Type: news

Gabapentin vs. Xanax
Title: Gabapentin vs. XanaxCategory: MedicationsCreated: 3/22/2018 12:00:00 AMLast Editorial Review: 3/22/2018 12:00:00 AM (Source: MedicineNet Medications General)
Source: MedicineNet Medications General - March 22, 2018 Category: Drugs & Pharmacology Source Type: news

Market Share, Costs of Biologic Therapies for IBD in the USA Market Share, Costs of Biologic Therapies for IBD in the USA
This study examined trends in the use of biologics for IBD, relative market share compared to other medication classes, and costs in the USA during a 9-year period.Alimentary Pharmacology & Therapeutics (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - March 22, 2018 Category: Consumer Health News Tags: Gastroenterology Journal Article Source Type: news

Novartis Drug Tasigna Approved by FDA to Treat Children with Rare Form of Leukemia
Basel, March 22, 2018 - Novartis announced today that the US Food and Drug Administration (FDA) expanded the indication for Tasigna (nilotinib) to include treatment of first- and second-line pediatric patients one year of age or older with... (Source: Drugs.com - New Drug Approvals)
Source: Drugs.com - New Drug Approvals - March 22, 2018 Category: Drugs & Pharmacology Source Type: news

Progenics Pharmaceuticals Announces Three-Month Extension of PDUFA Date for Azedra (iobenguane I 131)
NEW YORK, March 22, 2018 (GLOBE NEWSWIRE) -- Progenics Pharmaceuticals, Inc. (Nasdaq:PGNX), an oncology company developing innovative medicines and imaging analysis technology for targeting and treating cancer, announced today that the Company has... (Source: Drugs.com - New Drug Applications)
Source: Drugs.com - New Drug Applications - March 22, 2018 Category: Drugs & Pharmacology Source Type: news

FDA Approves Ilumya (tildrakizumab-asmn) for the Treatment of Moderate-to-Severe Plaque Psoriasis
MUMBAI, India and PRINCETON, N.J., March 21, 2018 /PRNewswire/ -- Sun Pharmaceutical Industries Ltd. today announced that the U.S. Food and Drug Administration (FDA) has approved Ilumya (tildrakizumab-asmn) for the treatment of adults with... (Source: Drugs.com - New Drug Approvals)
Source: Drugs.com - New Drug Approvals - March 21, 2018 Category: Drugs & Pharmacology Source Type: news

Betaine Hydrochloride (Cystadane) for Oral Solution (Updated - Resolved)
Drug Shortage (Source: FDA Drug Shortages)
Source: FDA Drug Shortages - March 21, 2018 Category: Drugs & Pharmacology Source Type: news

Common pain relievers may raise risk of irregular heartbeat, study says
A new study is adding to concerns about some common painkillers. The research reported in the British Journal of Clinical Pharmacology looks at prescription, non-steroid, anti-inflammatory drugs. People taking these pain relievers had an 18 percent higher risk of irregular heartbeat. Dr. Tara Narula joins "CBS This Morning" to discuss the findings. (Source: Health News: CBSNews.com)
Source: Health News: CBSNews.com - March 21, 2018 Category: Consumer Health News Source Type: news

Nigeria:Varsity Don Identifies Herbal Treatment for Epilepsy, Mental Illness
[Daily Trust] Kaduna -A Professor of Pharmacology and Toxicology at the Faculty of Pharmaceutical Sciences, Kaduna State University (KASU), Ben A. Chindo has identified that a plant scientifically known as Ficus Platyphylla, could be used for the management of central nervous system (CNS) disorders. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - March 21, 2018 Category: African Health Source Type: news

Singulair (Montelukast Sodium) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - March 21, 2018 Category: Drugs & Pharmacology Source Type: news

Mytesi (Crofelemer Delayed-release Tablets, for Oral Use) - new on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - March 21, 2018 Category: Drugs & Pharmacology Source Type: news

Cimduo (Lamivudine and Tenofovir Disoproxil Fumarate Tablets, for Oral Use) - new on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - March 21, 2018 Category: Drugs & Pharmacology Source Type: news

Cyfolex (Cholecalciferol, Folic Acid, Calcium Carbonate, and Bovine Type I Collagen Capsules) - new on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - March 21, 2018 Category: Drugs & Pharmacology Source Type: news

Reducing Adverse Drug Reactions in Older Adults Reducing Adverse Drug Reactions in Older Adults
Are interventions which aim to optimize medication use effective in reducing adverse drug reactions in older adults?Journal of the American Geriatrics Society (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - March 21, 2018 Category: Consumer Health News Tags: Family Medicine/Primary Care Journal Article Source Type: news

FDA Approves Genentech ’s Lucentis (ranibizumab injection) 0.3 mg Prefilled Syringe for Diabetic Macular Edema and Diabetic Retinopathy
South San Francisco, CA -- March 21, 2018 -- Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), today announced that the U.S. Food and Drug Administration (FDA) approved the Lucentis (ranibizumab injection) 0.3 mg prefilled syringe... (Source: Drugs.com - New Drug Approvals)
Source: Drugs.com - New Drug Approvals - March 21, 2018 Category: Drugs & Pharmacology Source Type: news

FDA Expands Approval of Adcetris (brentuximab vedotin) for First-Line Treatment of Stage III or IV Classical Hodgkin Lymphoma in Combination with Chemotherapy
March 20, 2018 -- The U.S. Food and Drug Administration today approved Adcetris (brentuximab vedotin) to treat adult patients with previously untreated stage III or IV classical Hodgkin lymphoma (cHL) in combination with... (Source: Drugs.com - New Drug Approvals)
Source: Drugs.com - New Drug Approvals - March 20, 2018 Category: Drugs & Pharmacology Source Type: news

Scorpion venom: A natural remedy for rheumatoid arthritis?
(Natural News) Although scorpion venom is one of the deadliest chemicals in the world, it’s also one of the most useful. Multiple studies have shown this neurotoxin to have tremendous potential in the field of human medicine. The most recent of these studies, published in the Journal of Pharmacology and Experimental Therapeutics, has discovered yet... (Source: NaturalNews.com)
Source: NaturalNews.com - March 20, 2018 Category: Consumer Health News Source Type: news

Proton Pump Inhibitors vs. Zantac
Title: Proton Pump Inhibitors vs. ZantacCategory: MedicationsCreated: 3/20/2018 12:00:00 AMLast Editorial Review: 3/20/2018 12:00:00 AM (Source: MedicineNet Medications General)
Source: MedicineNet Medications General - March 20, 2018 Category: Drugs & Pharmacology Source Type: news

Switching From Infliximab to Biosimilar in Patients With IBD Switching From Infliximab to Biosimilar in Patients With IBD
Two infliximab biosimilars are currently available for the treatment of inflammatory bowel disease, at a much lower cost than infliximab innovator. Can patients be safely switched?Alimentary Pharmacology & Therapeutics (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - March 20, 2018 Category: Consumer Health News Tags: Gastroenterology Journal Article Source Type: news

Pregnancy outcomes after suicide attempts by self-poisoning and drug overdose: experience of a clinical pharmacology consultation service in Izmir, Turkey - Ozturk Z, Ugras K.
[Abstract unavailable] Language: en... (Source: SafetyLit)
Source: SafetyLit - March 19, 2018 Category: International Medicine & Public Health Tags: Alcohol and Other Drugs Source Type: news

Tree Weed Feathers Mold Penicillium Allergenic Extracts (Tree Weed Feathers Mold Penicillium Allergenic Extracts) - new on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - March 19, 2018 Category: Drugs & Pharmacology Source Type: news

Insect Allergenic Extracts (Ant, Fly, Cockroach, and Mosquito Allergenic Extracts ) - new on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - March 19, 2018 Category: Drugs & Pharmacology Source Type: news

Center-Al (Allergenics Extracts Alum Precipitated Injection, Suspension) - new on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - March 19, 2018 Category: Drugs & Pharmacology Source Type: news

Cathflo Activase (Alteplase Powder for Reconstitution for Use in Central Venous Access Devices) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - March 19, 2018 Category: Drugs & Pharmacology Source Type: news

RPS talks to BBC Breakfast about painkiller addiction
Prescriptions for opioid painkillers have risen in England by almost 80% over the past decade according to the latest Prescription Analysis Data from NHS Digital. GPs in England prescribed 23.8 millio (Source: Royal Pharmaceutical Society News)
Source: Royal Pharmaceutical Society News - March 16, 2018 Category: Drugs & Pharmacology Source Type: news

Pharmacists funded to work in care homes in England
RespondingNHS England’s announcement it will fund180 pharmacists and 60 pharmacy technicians to work in care homes RPS England Board Chair Sandra Gidley said:““Our overstretched NH (Source: Royal Pharmaceutical Society News)
Source: Royal Pharmaceutical Society News - March 16, 2018 Category: Drugs & Pharmacology Source Type: news